In a young female of reproductive age an absolute contraindication for prescribing OCP&;s is
## **Core Concept**
The use of Oral Contraceptive Pills (OCPs) is influenced by various factors including age, smoking status, and presence of certain medical conditions. The question pertains to identifying an absolute contraindication for prescribing OCPs in a young female of reproductive age. This involves understanding the risks associated with estrogen and progesterone-containing medications.
## **Why the Correct Answer is Right**
The correct answer, **. History of thromboembolic events**, is an absolute contraindication because OCPs, especially those with estrogen, increase the risk of thrombosis and thromboembolism. This is due to their effect on coagulation factors and potential to induce a hypercoagulable state. A history of thromboembolic events signifies an increased susceptibility to such complications.
## **Why Each Wrong Option is Incorrect**
- **Option A: Hypertension**: While hypertension is a concern and needs careful monitoring, it is not an absolute contraindication. Some OCPs may be prescribed with caution, especially if the blood pressure is well-controlled.
- **Option B: Breastfeeding**: Breastfeeding is a relative contraindication, particularly in the early stages. However, it does not fall under absolute contraindications as the decision may depend on the duration of breastfeeding and other factors.
- **Option C: Migraine with aura**: This condition is associated with an increased risk of stroke and is considered a relative contraindication for combined OCPs. The risk-benefit analysis often guides the decision.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that a history of thromboembolic events is a significant concern for OCP use. Clinicians must assess the risk of venous thromboembolism (VTE) in patients before prescribing OCPs. The presence of a history of VTE shifts the balance towards avoiding estrogen-containing OCPs due to the increased risk of recurrence.
## **Correct Answer: . History of thromboembolic events**